The Enterprise Value as of November 2024 (TTM) for GSK plc (GLAXF) is 50.92B

According to GSK plc’s latest financial reports and current stock price. The company's current Enterprise Value is 50.92B. This represents a change of -29.52% compared to the average of 72.24B of the last 4 quarters.

GSK plc (GLAXF) Historical Enterprise Value (quarterly & annually)

How has GLAXF Enterprise Value performed in the past?

The mean historical Enterprise Value of GSK plc over the last ten years is 85.73B. The current 50.92B Enterprise Value has changed 5.84% with respect to the historical average. Over the past ten years (40 quarters), GLAXF's Enterprise Value was at its highest in in the June 2022 quarter at 127.25B. The Enterprise Value was at its lowest in in the September 2024 quarter at 57.93B.

GSK plc (GLAXF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of GSK plc Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

GSK plc (GLAXF) Average Enterprise Value

How has GLAXF Enterprise Value performed in the past?

The current Enterprise Value of GSK plc (GLAXF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

GSK plc (GLAXF) Enterprise Value vs. Peers

How is GLAXF’s Enterprise Value compared to its peers?

GSK plc’s Enterprise Value is less than Santen Pharmaceutical Co., Ltd. (458.60B), less than Ono Pharmaceutical Co., Ltd. (843.81B), greater than Grifols, S.A. (6.05B), less than Pfizer Inc. (210.88B), less than Sanofi (133.10B), less than Roche Holding AG (234.35B), less than Novartis AG (222.57B), less than Amgen Inc. (209.71B), less than Gilead Sciences, Inc. (135.65B), less than Roche Holding AG (238.14B), less than AstraZeneca PLC (234.40B), less than Roche Holding AG (227.52B), less than Novartis AG (222.02B), less than Bristol-Myers Squibb Company PFD CONV 2 (183.67B), less than Astellas Pharma Inc. (0), less than Bristol-Myers Squibb Company (3.37T), less than AstraZeneca PLC (162.91B), less than null (230.26B),

Build a custom stock screener for GSK plc (GLAXF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like GSK plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

GSK plc (GLAXF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like GSK plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.